These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9376348)

  • 1. Extracellular cysteines of the corticotropin-releasing factor receptor are critical for ligand interaction.
    Qi LJ; Leung AT; Xiong Y; Marx KA; Abou-Samra AB
    Biochemistry; 1997 Oct; 36(41):12442-8. PubMed ID: 9376348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of N-terminal domains for corticotropin-releasing factor (CRF) receptor-ligand interactions.
    Klose J; Fechner K; Beyermann M; Krause E; Wendt N; Bienert M; Rudolph R; Rothemund S
    Biochemistry; 2005 Feb; 44(5):1614-23. PubMed ID: 15683245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alanine scanning mutagenesis of the second extracellular loop of type 1 corticotropin-releasing factor receptor revealed residues critical for peptide binding.
    Gkountelias K; Tselios T; Venihaki M; Deraos G; Lazaridis I; Rassouli O; Gravanis A; Liapakis G
    Mol Pharmacol; 2009 Apr; 75(4):793-800. PubMed ID: 19124613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The three-dimensional structure of the N-terminal domain of corticotropin-releasing factor receptors: sushi domains and the B1 family of G protein-coupled receptors.
    Perrin MH; Grace CR; Riek R; Vale WW
    Ann N Y Acad Sci; 2006 Jul; 1070():105-19. PubMed ID: 16888152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides.
    Behan DP; De Souza EB; Lowry PJ; Potter E; Sawchenko P; Vale WW
    Front Neuroendocrinol; 1995 Oct; 16(4):362-82. PubMed ID: 8557170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
    Frändberg PA; Doufexis M; Kapas S; Chhajlani V
    Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
    Hoare SR; Sullivan SK; Schwarz DA; Ling N; Vale WW; Crowe PD; Grigoriadis DE
    Biochemistry; 2004 Apr; 43(13):3996-4011. PubMed ID: 15049707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.
    Dautzenberg FM; Wille S
    Regul Pept; 2004 May; 118(3):165-73. PubMed ID: 15003833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoaffinity cross-linking of the corticotropin-releasing factor receptor type 1 with photoreactive urocortin analogues.
    Kraetke O; Holeran B; Berger H; Escher E; Bienert M; Beyermann M
    Biochemistry; 2005 Nov; 44(47):15569-77. PubMed ID: 16300406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and characterization of a short variant of the corticotropin-releasing factor receptor subtype from rat amygdala.
    Miyata I; Shiota C; Ikeda Y; Oshida Y; Chaki S; Okuyama S; Inagami T
    Biochem Biophys Res Commun; 1999 Mar; 256(3):692-6. PubMed ID: 10080961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [¹²⁵I]YP20: a novel radioligand specific for the extracellular domain of the CRF₁ receptor.
    Gordon JC; Edwards P; Elmore CS; Lazor LA; Paschetto K; Bostwick R; Sylvester M; Mauger R; Scott C; Aharony D
    Eur J Pharmacol; 2010 Dec; 649(1-3):59-63. PubMed ID: 20854803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A variant of the human corticotropin-releasing factor (CRF) receptor: cloning, expression and pharmacology.
    Ross PC; Kostas CM; Ramabhadran TV
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1836-42. PubMed ID: 7811272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monkey corticotropin-releasing factor1 receptor: Complementary DNA cloning and pharmacological characterization.
    Oshida Y; Ikeda Y; Chaki S; Okuyama S
    Life Sci; 2004 Feb; 74(15):1911-24. PubMed ID: 14761672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An intramolecular disulfide bond between conserved extracellular cysteines in the gonadotropin-releasing hormone receptor is essential for binding and activation.
    Cook JV; Eidne KA
    Endocrinology; 1997 Jul; 138(7):2800-6. PubMed ID: 9202220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hexa-histidin tag position influences disulfide structure but not binding behavior of in vitro folded N-terminal domain of rat corticotropin-releasing factor receptor type 2a.
    Klose J; Wendt N; Kubald S; Krause E; Fechner K; Beyermann M; Bienert M; Rudolph R; Rothemund S
    Protein Sci; 2004 Sep; 13(9):2470-5. PubMed ID: 15295109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric ligands for the corticotropin releasing factor type 1 receptor modulate conformational states involved in receptor activation.
    Hoare SR; Fleck BA; Gross RS; Crowe PD; Williams JP; Grigoriadis DE
    Mol Pharmacol; 2008 May; 73(5):1371-80. PubMed ID: 18239030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A disulfide bonding interaction role for cysteines in the extracellular domain of the thyrotropin-releasing hormone receptor.
    Cook JV; McGregor A; Lee T; Milligan G; Eidne KA
    Endocrinology; 1996 Jul; 137(7):2851-8. PubMed ID: 8770906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
    Hoare SR; Sullivan SK; Fan J; Khongsaly K; Grigoriadis DE
    Peptides; 2005 Mar; 26(3):457-70. PubMed ID: 15652653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The functional role of cysteines adjacent to the NRY motif of the human MT1 melatonin receptor.
    Kokkola T; Salo OM; Poso A; Laitinen JT
    J Pineal Res; 2005 Aug; 39(1):1-11. PubMed ID: 15978051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization and characterization of a short isoform of the corticotropin-releasing factor receptor type 2alpha (CRF(2)alpha-tr) in the rat brain.
    Miyata I; Shiota C; Chaki S; Okuyama S; Inagami T
    Biochem Biophys Res Commun; 2001 Jan; 280(2):553-7. PubMed ID: 11162554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.